Evodiamine promotes LAST1 phosphorylation and inhibits YAP1 expression in HCC cells, resulting in YAP1 phosphorylation and reduced nuclear translocation, thus inactivating its downstream effector molecules (182). This evidence concerns the gene YAP1 and hepatocellular carcinoma.